Autoimmune antiphospholipid antibodies and cryoglobulinemia

Lupus

Volumn 9, Issue 4, 2000, Pages 264-270

  Hanly, J G ^a,b   Smith, S A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Antiphospholipid antibodies; Cryoglobulinemia

Indexed keywords

ANTIGEN; BETA2 GLYCOPROTEIN 1; CRYOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CRYOGLOBULINEMIA; CRYOPRECIPITATE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SEROLOGY;

EID: 0034064156     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120300680198953     Document Type: Article

References (44)

1. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-280.
2. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid' autoantibodies. Blood 1994; 84: 2854-2867.
3. Roubey R. Immunology of the antiphospholipid syndrome. Arthritis Rheum 1996; 39: 1444-1454.
4. Harris EN, Gharavi AE, Wasley GD, Hughes GRV. Use of an enzyme-linked immunosorhent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J Infect Dis 1988; 157: 23-31.
5. 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 1: 75-81.
6. Vaarala O, Palosuo T, Kleemola M et al. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986; 41: 8-15.
7. Zarrabi MH, Zucker S, Miller F et al. Immunologic and coagulation disorders in chlorpromazine-trealed patients. Ann Intern Med 1979; 91: 194-199.
8. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4125.
9. Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin hut to a plasma protein cofactor. Lancet 1990; 335: 1544-1547.
10. Severs EM, Galli M. Beta 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 1990; 336: 952-953.
11. Matsuura E, Igarashi Y, Fujimoto M et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 366: 177.
12. Asherson R, Khamashta M, Ordi-Ros J et al. The 'primary' antiphospholipid syndrome: major clinical and serologic features. Medicine 1988; 68: 366-374.
13. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Ann Intern Med 1990; 112: 682-698.
14. Cines DB, McCrae KR. The antiphospholipid-protein syndrome. J Clin Immunology 1995; 15(6)(Suppl): 86S-100S.
15. Shapiro SS. The lupus anticoagulant/antiphospholipid syndrome. Annu Rev Med 1996; 47: 533-553.
16. Nahass GT. Antiphospholipid antibodies and the antiphospholipid syndrome. J Am Acad Dermatol 1997; 36: 149-168.
17. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; In: 482-488.
18. Macworth-Young CG, Loizou S, Walport MJ. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989; 48: 362-367.
19. Alarcon-Segovia D, Deleze M, Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive cases. Medicine 1989; 68: 353-365.
20. Ginsberg JS, Wells PS. Brill-Edwards P et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685-3691.
21. Simioni P, Prandoni P, Zanon E et al. Deep venous thrombosis and lupus anticoagulant. A case-control study. Thromb Haemost 1996; 76: 187-189.
22. Goldberger E, Elder RC, Schwartz RA, Phillips PE. Vasculitis in the antiphospholipid syndrome. A cause of ischemia responding to corticosteroids. Arthritis Rheum 1992; 35: 569-572.
23. George J, Shoenfeld Y. The anti-phospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. Lupus 1997; 6: 559-560.
24. George J, Afek A, Gilburd B et al. Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. Lupus 1997; 6: 723-729.
25. Vaarala O, Manttari M, Manninen V et al. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995; 91: 23-27.
26. Del Papa N, Meroni PL, Tincani A et al. Relationship between antiphospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine activated endothelial cells. Clin Exp Rheumatol 1992; 10: 37-42.
27. Simantov R, LaSala JM, Lo SK et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96: 2211-2219.
28. 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997; 40: 551-561.
29. Asano T, Furie BC, Furie B. Platelet binding properties of monoclonal lupus autoantibodies produced by human hybridomas. Blood 1985; 66: 1254-1260.
30. Rauch J, Meng Q-H, Tannenbaum H. Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies. J Immunol 1987; 139: 2598-2604.
31. Khamashta MA, Harris EN, Gharavi AE et al. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 1988; 47: 849-854.
32. 2-glycoprotein-I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Blood 1998; 91: 1999-2004.
33. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
34. Hanly JG, Hassan J, Whelan A et al. Effects of gold therapy on synthesis and quantity of serum and synovial IgM, IgG and IgA rheumatoid factors in rheumatoid arthritis patients. Arthritis Rheum 1986; 29: 480-487.
35. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 728-734.
36. McNeil HP, Krilis SA, Chesterman CN. Purification of antiphospholipid antibodies using a new affinity method. Thromb Res 1988; 52: 641-648.
37. Hanly JG, Hong C, White TD. Brain synaptosomal antibodies in systemic lupus erythematosus. Lupus 1993; 2: 35-45.
38. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-1190.
39. Loeliger A. Prothrombin as cofactor in the circulating anticoagulant in systemic lupus erythematosus? Thromb Diath Haemorrh 1959; 3: 237.
40. Bevers EM, Galli M, Barbui T et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-632.
41. Yancey WB, Edwards NL, Williams RC. Cryoglobulins in a patient with SLE, livedo reticularis and elevated levels of anticardiolipin antibodies. Am J Med 1990; 88: 699.
42. Asherson RA, D'Cruz, Hughes GRV. Cryoglobulins, anticardiolipin antibodies and livedo reticularis. J Rheumatol 1992; 19: 826.
43. Brouet JC, Clauvel JP, Danon F et al. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775-788.
44. George J, Gilburd B, Langevitz P et al. Beta 2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels. Lupus 1999; 8: 116-120.